Table 4.
Clinical and demographical datas of the groups.
| Covid-19 (−) pneumonia (N = 42) |
Covid-19 pneumonia (N = 30) |
CT negative Covid-19 infection (N = 42) |
p-Value | ||||
|---|---|---|---|---|---|---|---|
| Mean ± SD | Median (IQR) |
Mean ± SD | Median (IQR) |
Mean ± SD | Median (IQR) |
||
| GRP-78 | 1276.65 ± 331.65 | 1283.13 (1018,05–1536.62) |
1462.13 ± 489 | 1474.86 (1002–1784.71) |
1662.18 ± 1088.6 | 1420.7 (1269.9–1594.5) |
1p = 0.09 2p = 0.517 3p = 0.656 |
| CURB-65 score | 1.29 ± 1 | 1 (1–2) | 1.32 ± 0.98 | 1 (0.5–2) | 2p = 0.942 | ||
| PSI score | 79.17 ± 42.52 | 80.5 (37.75–123.5) | 75.72 ± 37.96 | 68 (45.75–111.75) | 2p = 0.803 | ||
| Symptom duration (Day) |
4.78 ± 4.09 | 3 (2–7) | 6 ± 6.03 | 4 (2.5–6.5) | 4.03 ± 3.93 | 2 (2–5) | 2p = 0.177 |
GRP78, Glucose Regulated Protein; PSI, pneumonia severity index, CT, computed tomography.
1
p-Value derived from Kruskal-Wallis test and refers to the comparison between both subgroups.
2
p-Value is derived from Mann Whitney U test, and refers to the comparison between Covid-19 (−) pneumonia and Covid-19 pneumonia subgroups.
3
p-Value is derived from Mann Whitney U test and refers to the comparison between CT Negative Covid 19 Infection and Covid19 pneumonia subgroups.